Form 4: Bicycle Therapeutics CEO Kevin Lee Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Kevin Lee sold 3,212 ordinary shares of Bicycle Therapeutics PLC to cover statutory tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
Summary
- On October 3, 2024, Kevin Lee, CEO of Bicycle Therapeutics PLC, sold 3,212 ordinary shares.
- The sale was executed to cover statutory tax withholding obligations associated with the vesting and settlement of RSUs.
- The shares were sold at a weighted average price of $22.26, with individual transactions ranging from $21.91 to $22.56.
- Following the transaction, Lee directly owns 380,864 ordinary shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are standard practice for company insiders and officers, like the CEO, to report transactions in their company's stock. This provides transparency to the market.
Stakeholder Impact
- The sale is unlikely to have a significant impact on stakeholders as it is a small percentage of the CEO's holdings and is for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 10/03/2024 | Date of the share sale transaction. |
| 10/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.